Analysis of information sources in references of the Wikipedia article "Betsy DeVos" in English language version.
Within 90 days of my confirmation, I will divest my interests in the entities listed in Attachment A. With regard to each of these entities, I will not participate personally and substantially in any particular matter that to my knowledge has a direct and predictable effect on the financial interests of the entity until I have divested it, unless I first obtain a written waiver, pursuant to 18 U.S.C. § 208(b)(l), or qualify for a regulatory exemption, pursuant to 18 U.S.C. § 208(b )(2).
The Senate Committee on Health, Education, Labor and Pensions (HELP) on Tuesday morning approved Betsy DeVos's nomination to lead the Department of Education. DeVos was confirmed 12–11 along party lines.
TINA.org is not the first to challenge Neurocore's unsubstantiated health claims. In 2017, the National Advertising Division recommended that Neurocore discontinue several disease-treatment claims after it found evidence proffered by the company in support of the claims "insufficiently reliable" to substantiate them.
We write to file a complaint with the U.S. Food and Drug Administration against Michigan-based "brain training" company Neurocore, LLC1 for its marketing, use, and sale of unapproved medical devices.
Neurocore's deceptive marketing is used to attract vulnerable consumers, many of whom struggle with difficult psychiatric disorders, are caring for children who struggle with such disorders, or are seniors dealing with age-related memory loss, to its Brain Performance Centers. The consumer harm associated with deceiving these susceptible populations is of great concern and must be stopped.
DeVos grew up in the Christian Reformed Church and graduated from schools affiliated with the tradition: Holland Christian Schools in Holland, Mich., and Calvin College in Grand Rapids, Mich.
Perhaps the most notable individual on the list is Education Secretary Betsy DeVos, whose family invested $100 million—literally 100 times the lifetime earnings of the average American—in Theranos between 2013 and 2015. (DeVos had previously disclosed that she was a Theranos investor, though the size of her investment was not known.)
TINA.org is not the first to challenge Neurocore's unsubstantiated health claims. In 2017, the National Advertising Division recommended that Neurocore discontinue several disease-treatment claims after it found evidence proffered by the company in support of the claims "insufficiently reliable" to substantiate them.
We write to file a complaint with the U.S. Food and Drug Administration against Michigan-based "brain training" company Neurocore, LLC1 for its marketing, use, and sale of unapproved medical devices.
Neurocore's deceptive marketing is used to attract vulnerable consumers, many of whom struggle with difficult psychiatric disorders, are caring for children who struggle with such disorders, or are seniors dealing with age-related memory loss, to its Brain Performance Centers. The consumer harm associated with deceiving these susceptible populations is of great concern and must be stopped.
Within 90 days of my confirmation, I will divest my interests in the entities listed in Attachment A. With regard to each of these entities, I will not participate personally and substantially in any particular matter that to my knowledge has a direct and predictable effect on the financial interests of the entity until I have divested it, unless I first obtain a written waiver, pursuant to 18 U.S.C. § 208(b)(l), or qualify for a regulatory exemption, pursuant to 18 U.S.C. § 208(b )(2).
{{cite web}}: CS1 maint: unfit URL (link){{cite news}}: CS1 maint: multiple names: authors list (link){{cite news}}: CS1 maint: multiple names: authors list (link)